A Randomized, Open-label, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of Ondansetron compared to Metoclopramide in the management of Nausea and Vomiting in Adult Patients with Acute Gastroenteritis.
Male or female patients aged between 18 and 65 years.
Patients diagnosed with acute gastroenteritis visiting the emergency room.
Patients considered by the attending physician to need an anti-emetic medication.
Patients able and willing to provide written informed consent.
Pregnant or lactating women.
Patients who received an anti-emetic medication during the past 24 hours.
History of hypersensitivity to any components of ondansetron or metoclopramide injection.
History of hypersensitivity to other selective 5HT3 receptor antagonists.
Genuine Research Center, Egypt
Lead sponsor
Adwia Pharma, Egypt
Collaborator